Omega-3 (EPA+DHA)

DIETARY_SUPPLEMENT3 trials

Sponsors

Hackensack Meridian Health, North-West University, South Africa, Izmir Katip Celebi University

Conditions

COVID-19Clinical OutcomesInflammation BiomarkersIron StatusLiver Function TestsMetabolomicsNutritional StatusPeriodontitis

Phase 1

Feasibility Pilot Clinical Trial of Omega-3 Supplement vs. Placebo for Post Covid-19 Recovery Among Health Care Workers

TerminatedNCT05121766

Hackensack Meridian HealthCOVID-19

Start: 2022-01-10End: 2023-04-21Updated: 2024-09-19

Phase 2

Effects of Adjunct Omega-3 Long Chain Polyunsaturated Fatty Acids in Pulmonary Tuberculosis Patient: an Early Bactericidal Activity and Inflammatory Trial

RecruitingNCT07118059

North-West University, South AfricaClinical Outcomes, Inflammation Biomarkers, Iron Status +4

Start: 2026-08-19End: 2027-12-01Target: 40Updated: 2026-09-09

Unknown Phase

Comparative Evaluation of Omega-3 and Resveratrol Supplementation in Periodontitis Patients

Active, not recruitingNCT07827391

Izmir Katip Celebi UniversityPeriodontitis

Start: 2025-01-01End: 2028-03-15Target: 60Updated: 2026-09-18